Slide 1: Year-End Report January - December 2014
Year-End Report January - December 2014 Johan Malmquist, CEO and Ulf Grunander, CFO January 28, 2015 Page 1
Slide 2: Trends in organic order intake
Q4 2014 Trends in organic order intake 2014 2014 Q4 YTD MS EC IC TOT MS EC IC TOT Western Europe 1,0 % -3,7 % 9,3 % 1,1 % 0,4 % -1,9 % 6,7 % 1,0 % USA and Canada 8,6 % -2,3 % 3,7 % 4,4 % 3,6 % -1,6 % 3,6 % 2,0 % Rest of the world 3,2 % 0,6 % 7,8 % 3,7 % -3,3 % 7,5 % 0,4 % -1,1 % Total 4,2 % -2,6 % 7
Slide 3: Consolidated Results
Q4 2014 Consolidated Results 2014 2013 2014 2013 Q4 Q4 Change % YTD YTD Change % Net sales, SEK million 8 458 7 757 9,0 % 26 669 25 287 5,5 % Gross margin 49,4 % 51,5 % -2,1 % 49,2 % 50,4 % -1,2 % Operating cost, SEK -2 360 -2 080 13,5 % -9 264 -8 585 7,9 % million EBITA before 1 994 2 060 -3,2 % 4
Slide 4: Medical Systems
Q4 2014 Medical Systems 2014 2013 2014 2013 Change % Change % Q4 Q4 YTD YTD Net sales, SEK million 4 702 4 312 9,0 % 14 105 13 322 5,9 % Gross margin % 54,4 % 56,4 % -2,0% 55,0 % 56,2 % -1,2 % Operating cost, SEK -1 386 -1 191 16,4 % -5 390 -5 051 6,7 % million EBITA before restructuring 1 309 1 353
Slide 5: Medical Systems - Highlights
Q4 2014 Medical Systems - Highlights Likely outcome of the ongoing dialogue with the US FDA: Getinge committed an additional SEK 175 M in the period to complete the quality management system remediation program Although no definitive agreement has been concluded, Getinge estimates that the lik
Slide 6: Extended Care
Q4 2014 Extended Care 2014 2013 2014 2013 Change % Change % Q4 Q4 YTD YTD Net sales, SEK million 2 002 1 840 8,8 % 7 164 6 870 4,3 % Gross margin % 49,1 % 50,7 % -1,6 % 47,4 % 48,4 % -1,0 % Operating cost, SEK million -615 -511 20,4 % - 2 494 -2 161 15,4 % EBITA before restructuring 403 452 -10,8 %
Slide 7: Extended Care - Highlights
Q4 2014 Extended Care - Highlights Launch of SafeSet - a visual alerts system for medical beds Further measures to improve commercial operations The quarter was charged with restructuring costs amounting to SEK 55 M. The measures are expected to generate annual savings of about SEK 60 M from 201
Slide 8: Infection Control
Q4 2014 Infection Control 2014 2013 2014 2013 Change % Change % Q4 Q4 YTD YTD Net sales, SEK million 1 754 1 606 9,2 % 5 400 5 095 6,0 % Gross margin % 36,4 % 39,2 % -2,8 % 36,2 % 38,0 % -1,8 % Operating cost, SEK million -361 -380 -5,0% -1 380 -1 377 0,2% EBITA before restructuring 283 254 11,4% 59
Slide 9: Infection Control - Highlights
Q4 2014 Infection Control - Highlights Joacim Lindoff appointed new Executive Vice President The efficiency-enhancement program to improve the business area’s profitability progresses Closure of Mansfield, UK, and transfer of sterilizer to Getinge, Sweden, concluded during the period Union n
Slide 10: Financials Q4
Financials Q4 2014 2013 2014 2013 Q4 Q4 YTD YTD Cash flow from operations, SEK million 1 376 1 410 3 473 3 544 Cash conversion, % 65,6 % 60,4 % 72,9 % 63,1 % Net Debt, SEK million 22 541 18 319 Equity, SEK million 18 694 16 560 Equity / assets ratio, % 35,4 % 37,4% Net debt / equity ratio, multiple
Slide 11: Outlook
GETINGE GROUP Outlook
Slide 12: Outlook 2015
Outlook 2015 Organic revenue growth is expected to improve in 2015 • The outcome of the ongoing discussions with the US FDA is expected to have a negative financial impact of approx. SEK 500 M on operating profit for 2015. • FX effects are expected to positively impact 2015 pre-tax earnings in the
Slide 13: Page 13
GETINGE GROUP
Slide 14: Forward-looking Information
Forward-looking Information This document contains forward-looking information based on the current expectations of the Getinge Group’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expec
Slide 15: Getinge Group company description
Getinge Group is a global leading medical technology company that operates in the areas of surgery, intensive care, infection control, care ergonomics and wound care. Getinge Group has more than 15,000 employees in over 40 countries and generates sales exceeding SEK 25 billion (2013). The Group is d